Abstract
Local tumour control in conjunctival melanoma has improved in recent years. However the tumour-related death rate of these patients is still 14% at 5 years up to 33% at 15 years. With the introduction of sentinel node biopsies for conjunctival melanomas with a poor prognosis and screening for locoregional and distant metasases prognosis might be improved.
MeSH terms
-
Combined Modality Therapy
-
Conjunctival Neoplasms / diagnosis*
-
Conjunctival Neoplasms / mortality
-
Conjunctival Neoplasms / secondary*
-
Conjunctival Neoplasms / therapy
-
Humans
-
Mass Screening / methods*
-
Melanoma / diagnosis*
-
Melanoma / mortality
-
Melanoma / secondary*
-
Melanoma / therapy
-
Neoplasm Recurrence, Local
-
Prognosis
-
Sentinel Lymph Node Biopsy
-
Skin Neoplasms / mortality
-
Skin Neoplasms / pathology
-
Skin Neoplasms / therapy
-
Survival Rate